Alcohol, Obesity, Society, UK news, Diabetes, Science, Medical research, Health Business | The Guardian
Semaglutide, active ingredient of Wegovy and Ozempic, found to reduce cravings and cut drinking by 40%Weight-loss drugs could be used to help people reduce their intake of alcohol, researchers have said, after a study found they can cut cravings and curb heavy drinking.The medicines, originally developed to treat type 2 diabetes, have revolutionised the treatment of obesity, and evidence suggests they could have benefits in other areas of health, such as reducing risk of heart attacks and strokes. Continue reading…
Semaglutide, active ingredient of Wegovy and Ozempic, found to reduce cravings and cut drinking by 40%
Weight-loss drugs could be used to help people reduce their intake of alcohol, researchers have said, after a study found they can cut cravings and curb heavy drinking.
The medicines, originally developed to treat type 2 diabetes, have revolutionised the treatment of obesity, and evidence suggests they could have benefits in other areas of health, such as reducing risk of heart attacks and strokes.
